As of 2025-07-04, the Relative Valuation of Nuvo Pharmaceuticals Inc (MRV.TO) is 1.33 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.35 CAD, the upside of Nuvo Pharmaceuticals Inc based on Relative Valuation is -1.4%.
The range of the Relative Valuation is 1.33 - 1.33 CAD.
| Range | Selected | |
| Trailing P/E multiples | 1.0x - 1.0x | 1.0x |
| Forward P/E multiples | 1.0x - 1.0x | 1.0x |
| Fair Price | 1.33 - 1.33 | 1.33 |
| Upside | -1.4% - -1.4% | -1.4% |
| Date | P/E |